Abstract
Catrix-S is an acidic mucopolysaccharide complex derived from bovine tracheal cartilage. This material was administered by weekly subcutaneous injection (5.0-7.5 g/week) to nine patients with progressive metastatic malignancy. One complete response was seen in a patient with metastatic renal cell carcinoma to the lungs. Eight patients had progression of their disease. No undue toxicity and no consistent immunologic alteration was noted.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 585-589 |
| Number of pages | 5 |
| Journal | Journal of Biological Response Modifiers |
| Volume | 4 |
| Issue number | 6 |
| State | Published - Dec 1985 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Immunology
- Pharmacology
- Cancer Research
Fingerprint
Dive into the research topics of 'A phase II study of Catrix-S in solid tumors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver